Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 103 of the 104 references it cites were found in a registry or an index.

Current and emerging drug treatment strategies for polycystic ovary syndrome

Helvaci, Nafiye, Yildiz, Bulent Okan · 2023 · Expert Opinion on Pharmacotherapy

Abstract

INTRODUCTION: Polycystic ovary syndrome (PCOS) is a common hormonal, metabolic, and reproductive disorder with a heterogeneous phenotype. As the exact etiology of PCOS is still unclear, available pharmacotherapies are mostly directed toward alleviating symptoms and associated metabolic abnormalities. AREAS COVERED: Herein, we present an overview of the current and emerging pharmacotherapies for the management of women with PCOS who do not seek pregnancy. We performed a literature search in PubMed database up to January 2022 and reviewed papers assessing drug treatments for PCOS. We aimed to outline the most recent evidence to support treatment recommendations in these patients. EXPERT OPINION: Targets for medical treatment include hormonal, reproductive, and metabolic abnormalities in PCOS. However, none of the available pharmacological options can cover the entire spectrum of clinical manifestations observed in these patients. Considering the heterogeneity of PCOS, treatment should be individualized and adapted to specific needs of each patient. Better understanding of the molecular mechanisms underlying the pathogenesis of PCOS would help development of novel, safer, and more effective multi-targeted therapeutic strategies for the syndrome.

Overview

Integrity signals

Registry

Crossref · 10.1080/14656566.2022.2108702

Cites

103 of 103 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 104 references

Research works printed but not linked: 4

  1. Lopez LM, 2019, Cochrane Database Syst Rev, 2014, CD006133
  2. Fraison E, 2020, Cochrane Database Syst Rev, 8, CD005552
  3. Miao C, 2020, Exp Ther Med, 19, 2641
  4. Coutinho EA, 2019, Med Sci (Basel), 7, 84

Cited by

See all 38

Metadata

Authors
Helvaci, N., & Yildiz, B. O.
Affiliations
  • Division of Endocrinology and Metabolism, Department of Internal Medicine, Hitit University School of Medicine, Corum, Turkey
  • Division of Endocrinology and Metabolism, Department of Internal Medicine, Hacettepe University School of Medicine, Ankara, Turkey
Venue
Expert Opinion on Pharmacotherapy
Published
2022-08-07
Volume
24
Issue
1
Pages
105-120
ISSN
  • 1465-6566 (ISSN-L)
  • 1744-7666
OpenAlex
W4288884761
Cited by
35
References
104
Citations by year
2026: 12 · 2025: 6 · 2024: 10 · 2023: 7
FWCI
0.93
Type
journal article
Language
en
Open access
closed
Locations
  • Expert Opinion on Pharmacotherapy (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
  • Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
  • Health Sciences › Medicine › Reproductive Medicine › Reproductive Biology and Fertility
Keywords
polycystic ovary syndrome, pharmacotherapy, metabolic abnormalities, endocrine disorders, reproductive abnormalities, personalized treatment, multi-target therapy, PCOS pathogenesis
MeSH terms
Female, Humans, Phenotype, Polycystic Ovary Syndrome, Pregnancy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Current and emerging drug treatment strategies for polycystic ovary syndrome. https://app.cochat.ai/papers/10.1080/14656566.2022.2108702
The paper
Helvaci, N., & Yildiz, B. O. (2023). Current and emerging drug treatment strategies for polycystic ovary syndrome. Expert Opinion on Pharmacotherapy. https://doi.org/10.1080/14656566.2022.2108702

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.